Clinical trial
Patient Specific Talus Spacer Post Approval Study
NCT05364606 is registered in ClinicalTrials.gov with Paragon 28 as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient Specific Talus Spacer Post Approval Study
- Lead sponsor
- Paragon 28
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 8, 2022
- Completion date
- November 30, 2033
- Enrollment
- 50 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
avascular necrosis of the talus